Correlation Between Spero Therapeutics and Fortress Biotech

Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spero Therapeutics and Fortress Biotech Pref, you can compare the effects of market volatilities on Spero Therapeutics and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and Fortress Biotech.

Diversification Opportunities for Spero Therapeutics and Fortress Biotech

-0.39

Correlation Coefficient

Spero Therapeutics  Fortress Biotech

Very good diversification

The 3 months correlation between Spero and Fortress is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and Fortress Biotech Pref in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech Pref and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech Pref has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and Fortress Biotech go up and down completely randomly.

Pair Corralation between Spero Therapeutics and Fortress Biotech

Given the investment horizon of 90 days Spero Therapeutics is expected to under-perform the Fortress Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Spero Therapeutics is 2.23 times less risky than Fortress Biotech. The stock trades about -0.22 of its potential returns per unit of risk. The Fortress Biotech Pref is currently generating about 0.35 of returns per unit of risk over similar time horizon. If you would invest  510.00  in Fortress Biotech Pref on September 16, 2024 and sell it today you would earn a total of  188.00  from holding Fortress Biotech Pref or generate 36.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Spero Therapeutics  vs.  Fortress Biotech Pref

Spero Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spero Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Fortress Biotech Pref

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Fortress Biotech Pref are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Fortress Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Spero Therapeutics and Fortress Biotech

The main advantage of trading using opposite Spero Therapeutics and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.

The idea behind Spero Therapeutics and Fortress Biotech Pref pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.